Theratechnologies (THTX) Competitors $2.52 -0.05 (-1.95%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$2.52 0.00 (0.00%) As of 04/17/2025 06:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock THTX vs. HRTX, RGNX, VERV, TECX, ORKA, MREO, BNTC, AURA, CYRX, and ATXSShould you be buying Theratechnologies stock or one of its competitors? The main competitors of Theratechnologies include Heron Therapeutics (HRTX), REGENXBIO (RGNX), Verve Therapeutics (VERV), Tectonic Therapeutic (TECX), Oruka Therapeutics (ORKA), Mereo BioPharma Group (MREO), Benitec Biopharma (BNTC), Aura Biosciences (AURA), Cryoport (CYRX), and Astria Therapeutics (ATXS). These companies are all part of the "pharmaceutical products" industry. Theratechnologies vs. Heron Therapeutics REGENXBIO Verve Therapeutics Tectonic Therapeutic Oruka Therapeutics Mereo BioPharma Group Benitec Biopharma Aura Biosciences Cryoport Astria Therapeutics Theratechnologies (NASDAQ:THTX) and Heron Therapeutics (NASDAQ:HRTX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and community ranking. Does the MarketBeat Community prefer THTX or HRTX? Heron Therapeutics received 637 more outperform votes than Theratechnologies when rated by MarketBeat users. Likewise, 68.87% of users gave Heron Therapeutics an outperform vote while only 54.39% of users gave Theratechnologies an outperform vote. CompanyUnderperformOutperformTheratechnologiesOutperform Votes3154.39% Underperform Votes2645.61% Heron TherapeuticsOutperform Votes66868.87% Underperform Votes30231.13% Does the media refer more to THTX or HRTX? In the previous week, Theratechnologies had 18 more articles in the media than Heron Therapeutics. MarketBeat recorded 22 mentions for Theratechnologies and 4 mentions for Heron Therapeutics. Heron Therapeutics' average media sentiment score of 0.83 beat Theratechnologies' score of 0.00 indicating that Heron Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Theratechnologies 2 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Heron Therapeutics 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in THTX or HRTX? 80.0% of Heron Therapeutics shares are owned by institutional investors. 5.8% of Heron Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts recommend THTX or HRTX? Heron Therapeutics has a consensus target price of $5.67, suggesting a potential upside of 207.97%. Given Heron Therapeutics' higher possible upside, analysts clearly believe Heron Therapeutics is more favorable than Theratechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Theratechnologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 2 Strong Buy rating(s) 4.00Heron Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher earnings and valuation, THTX or HRTX? Theratechnologies has higher earnings, but lower revenue than Heron Therapeutics. Theratechnologies is trading at a lower price-to-earnings ratio than Heron Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTheratechnologies$85.87M1.35-$23.96M-$0.08-31.50Heron Therapeutics$144.29M1.94-$110.56M-$0.09-20.44 Which has more volatility & risk, THTX or HRTX? Theratechnologies has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Comparatively, Heron Therapeutics has a beta of 1.39, indicating that its share price is 39% more volatile than the S&P 500. Is THTX or HRTX more profitable? Theratechnologies has a net margin of -3.75% compared to Heron Therapeutics' net margin of -20.31%. Company Net Margins Return on Equity Return on Assets Theratechnologies-3.75% N/A -4.31% Heron Therapeutics -20.31%N/A -12.72% SummaryHeron Therapeutics beats Theratechnologies on 11 of the 18 factors compared between the two stocks. Get Theratechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for THTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart THTX vs. The Competition Export to ExcelMetricTheratechnologiesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$115.87M$6.44B$5.30B$7.35BDividend YieldN/A3.23%5.12%4.31%P/E Ratio-25.206.8821.7317.77Price / Sales1.35231.02379.1697.65Price / CashN/A65.6738.2234.64Price / Book-5.605.916.443.98Net Income-$23.96M$142.72M$3.21B$247.44M7 Day Performance29.90%4.33%2.82%1.82%1 Month Performance59.49%-12.80%-8.67%-6.98%1 Year Performance92.37%-9.71%11.32%1.49% Theratechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)THTXTheratechnologiesN/A$2.52-1.9%N/A+88.1%$115.87M$88.67M-25.20140Analyst RevisionHRTXHeron Therapeutics3.4869 of 5 stars$1.96-6.7%$5.67+189.1%-33.6%$298.57M$144.29M-10.89300Positive NewsRGNXREGENXBIO4.6947 of 5 stars$5.93-5.7%$32.78+452.7%-65.1%$297.01M$83.33M-1.18370Analyst ForecastAnalyst RevisionNews CoveragePositive NewsGap DownVERVVerve Therapeutics3.0792 of 5 stars$3.34-7.7%$20.67+518.8%-31.9%$296.58M$32.33M-1.36110Analyst ForecastOptions VolumeHigh Trading VolumeTECXTectonic Therapeutic2.8028 of 5 stars$15.53-0.6%$77.75+400.6%N/A$289.84MN/A-2.64120Short Interest ↑Positive NewsGap UpORKAOruka Therapeutics3.0849 of 5 stars$7.62-2.7%$39.86+423.1%N/A$285.30MN/A-1.22N/AUpcoming EarningsNews CoveragePositive NewsGap DownHigh Trading VolumeMREOMereo BioPharma Group2.0572 of 5 stars$1.83-8.0%$7.71+321.5%-10.9%$283.92M$1M-30.5040High Trading VolumeBNTCBenitec Biopharma2.2245 of 5 stars$12.02-2.4%$24.43+103.2%+186.5%$281.88M$80,000.00-7.9620Short Interest ↑Gap UpAURAAura Biosciences1.8345 of 5 stars$5.52+1.7%$22.75+312.1%-23.8%$277.24MN/A-3.1950Short Interest ↑CYRXCryoport2.5277 of 5 stars$5.49+2.8%$11.83+115.5%-66.9%$274.01M$228.39M-1.621,020Analyst ForecastAnalyst RevisionATXSAstria Therapeutics2.4671 of 5 stars$4.50-3.4%$26.60+491.1%-61.7%$262.70MN/A-2.1530Gap Down Related Companies and Tools Related Companies HRTX Competitors RGNX Competitors VERV Competitors TECX Competitors ORKA Competitors MREO Competitors BNTC Competitors AURA Competitors CYRX Competitors ATXS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:THTX) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThe Last Time Stocks Looked Like This, They Didn’t Move For 16 YearsThere is nothing the Federal Reserve can do to stop what's coming next for U.S. stocks. As you've seen your...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThey Won’t Tell You This About GoldInflation, digital currency, and government policy are quietly eating away at your savings — and most people w...American Alternative | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theratechnologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theratechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy THTX Stock Free THTX Stock Alerts